Having worked with the Waud Capital team once before, I was thrilled to kick off our second partnership with the launch of our enterprise application software campaign earlier this year. Waud’s executive partnership model and ecosystem of resources are foundational to their investment strategy and clear differentiators in the market. Following the launch of our campaign, we quickly got to work and are greatly excited by our investment in Science Exchange, a premier SaaS asset with significant potential and a strong value proposition in the life sciences vertical end market. I look forward to working alongside the executive leadership team and the Waud Capital team to execute upon this potential.
With Waud Capital’s support, we are poised to further solidify our position as the premier SaaS supplier orchestration platform in the life sciences industry. Our platform has already transformed how life sciences companies work with their suppliers, and this partnership will enable us to accelerate our product innovation, drive even faster growth, and expand our impact across the industry. Waud’s proven track record in scaling technology companies, combined with their deep experience in healthcare and life sciences, make them the ideal partner to help us unlock the next phase of Science Exchange's evolution.